These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
67 results:

  • 1. Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion.
    Li Y; Cui Q; Liu S; Liu L; Li M; Gao J; Li Z; Cui W; Zhu X; Kang L; Yu L; Wu D; Tang X
    Cell Oncol (Dordr); 2024 Oct; 47(5):1649-1661. PubMed ID: 38662336
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma.
    Lind J; Hellinger R; Kudweis P; Moll HP; Gattringer J; Thell K; Edtmayer S; Gruber CW; Stoiber D; Kollmann K
    Biomed Pharmacother; 2022 Sep; 153():113486. PubMed ID: 36076504
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma.
    Tang X; Yang ZZ; Kim HJ; Anagnostou T; Yu Y; Wu X; Chen J; Krull JE; Wenzl K; Mondello P; Bhardwaj V; Wang J; Novak AJ; Ansell SM
    Clin Cancer Res; 2022 Oct; 28(19):4322-4335. PubMed ID: 35686915
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Autologous hematopoietic stem cell transplantation followed by interleukin-2 for adult acute myeloid leukemia patients with favorable or intermediate risk after complete remission.
    Zeng Q; Xiang B; Liu Z
    Ann Hematol; 2022 Aug; 101(8):1711-1718. PubMed ID: 35570208
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia.
    Perkins B; Showel M; Schoch L; Imus PH; Karantanos T; Yonescu R; Morsberger L; Ghiaur G; Gladstone DE; Jones RJ
    Leuk Lymphoma; 2022 Jul; 63(7):1617-1623. PubMed ID: 35343368
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy and safety of chemotherapy combined with different doses of il-2 maintenance therapies for acute myeloid leukemia: A protocol for a Bayesian network meta-analysis.
    Yin X; Ding Y; Yu L; Guo C; Cui Y; Zhai X; Wang Y; Ding S; Shen M; Li Z; Xu R
    Medicine (Baltimore); 2021 Jun; 100(23):e26098. PubMed ID: 34114994
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor prognosis IGHV- Unmutated Chronic Lymphocytic leukemia.
    Maharaj D; Srinivasan G; Abreu MM; Ko MW; Jewett A; Gouvea J
    Cells; 2020 Dec; 10(1):. PubMed ID: 33375215
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. NK cells and ILCs in tumor immunotherapy.
    Sivori S; Pende D; Quatrini L; Pietra G; Della Chiesa M; Vacca P; Tumino N; Moretta F; Mingari MC; Locatelli F; Moretta L
    Mol Aspects Med; 2021 Aug; 80():100870. PubMed ID: 32800530
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immunorelated gene polymorphisms associated with acute myeloid leukemia.
    Liu Q; Hua M; Yan S; Zhang C; Wang R; Yang X; Han F; Hou M; Ma D
    Clin Exp Immunol; 2020 Sep; 201(3):266-278. PubMed ID: 32349161
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Application of CpG Oligodeoxynucleotide Immunostimulation in Chromosome Study of Chronic Lymphoblastic leukemia].
    Mai DI Na AEK; Liu H; Wang YL; Wang YC; Huang Q; Wang ZS; Gu ZLNE; Lang T; Nie YL; An L; A ZGL; Mu HTBE; Zhang XY; Fu L; Ai HMJ; Mao M; Wang XM; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):470-475. PubMed ID: 32319381
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Chromosomal aberrations detection in chronic lymphocytic leukemia by conventional cytogenetics using DSP30 and il-2].
    Liu HF; Huang HW; Bai SX; Gong YL; Wu CX; Jin ZM; Wang YY; Yang Q; Zhang J; Qiu HY; Chen SN; Pan JL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):143-148. PubMed ID: 32135632
    [No Abstract]    [Full Text] [Related]  

  • 12. Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients.
    Wu K; Feng J; Xiu Y; Li Z; Lin Z; Zhao H; Zeng H; Xia W; Yu L; Xu B
    Int Immunopharmacol; 2020 Mar; 80():106122. PubMed ID: 31955066
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. il-2/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells.
    Nakase K; Kita K; Katayama N
    Med Hypotheses; 2018 Jun; 115():5-7. PubMed ID: 29685196
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML.
    Björklund AT; Carlsten M; Sohlberg E; Liu LL; Clancy T; Karimi M; Cooley S; Miller JS; Klimkowska M; Schaffer M; Watz E; Wikström K; Blomberg P; Wahlin BE; Palma M; Hansson L; Ljungman P; Hellström-Lindberg E; Ljunggren HG; Malmberg KJ
    Clin Cancer Res; 2018 Apr; 24(8):1834-1844. PubMed ID: 29444931
    [No Abstract]    [Full Text] [Related]  

  • 16. Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells.
    Jung JI; Park KY; Kim SA; Kim J
    Biomed Pharmacother; 2018 Feb; 98():357-363. PubMed ID: 29275177
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cytokines and soluble HLA-G levels in bone marrow stroma and their association with the survival rate of patients exhibiting childhood T-cell acute lymphoblastic leukemia.
    Almeida RDS; Ramos AML; Luna CF; Pedrosa F; Donadi EA; Lucena-Silva N
    Cytokine; 2018 Feb; 102():94-101. PubMed ID: 28802664
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Galectin-9 as a Predictive Marker for the Onset of Immune-Related Adverse Effects Associated with Anti-CCR4 MoAb Therapy in Patients with Adult T Cell leukemia.
    Mohammed TO; Chagan-Yasutan H; Ashino Y; Nakayama W; Takahashi Y; Shimomura T; Fujimoto T; Watanabe Y; Niki T; Suzushima H; Hattori T
    Tohoku J Exp Med; 2017 Mar; 241(3):201-208. PubMed ID: 28321034
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.
    Rydström A; Hallner A; Aurelius J; Sander FE; Bernson E; Kiffin R; Thoren FB; Hellstrand K; Martner A
    J Leukoc Biol; 2017 Aug; 102(2):467-474. PubMed ID: 28235771
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy of DSP30-il2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Holmes PJ; Peiper SC; Uppal GK; Gong JZ; Wang ZX; Bajaj R
    Int J Lab Hematol; 2016 Oct; 38(5):483-9. PubMed ID: 27565124
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.